Reisa A. Sperling

Works at

Sources: reporter.nih.gov

Grants and prizes

  • National Institute on Aging

    P01, Impact of Amyloid and Tau on the Aging Brain: The Harvard Aging Brain Study, P01AG036694, 2010–2031, 28 Aug 2026

  • National Institute on Aging

    U24, Alzheimer's Clinical Trials Consortium (ACTC), U24AG057437, 2017–2028, 19 Aug 2026

  • National Institute on Aging

    R01, The Ante-Amyloid Treatment of Alzheimer's disease (A3) Trial and Alzheimer Plasma EXtension (APEX) Study, R01AG095009, 2025–2030, 19 Aug 2026

  • National Institute on Aging

    R01, API A4 Alzheimer's Prevention Trial, R01AG058468, 2018–2025, 11 Mar 2025

  • National Institute on Aging

    R01, Combination anti-amyloid therapy for preclinical Alzheimer's disease, R01AG061848, 2018–2025, 10 Jul 2024

  • National Institute on Aging

    R01, Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Open-Label Extension Study, R01AG063689, 2019–2025, 29 Dec 2023

  • National Institute on Aging

    R01, The A3 Study: Ante-Amyloid Prevention of Alzheimer's disease, R01AG054029, 2016–2024, 16 Jun 2023

Sources: reporter.nih.gov